FindTrial
Sign In

The prevalence and treatment of anemia in pre-dialysis patients with CKD1-5: multicenter survey in Shanghai .

The prevalence and treatment of anemia in pre-dialysis patients with CKD1-5: multicenter survey in Shanghai .

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ECS-12002383
Enrollment
Unknown
Registered
2012-07-30
Start date
2012-07-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney diease

Interventions

1:NA

Sponsors

Shanghai Jiaotong University School of Medicine, Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. patients with written informed consent; 2. the CKD1-5 non-dialysis inpatient or outpatient, age 18 to 75-year-old, male or female; according to the KDOQI CKD diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. in pregnancy or lactating women; 2. hemodialysis or peritoneal dialysis patients; 3. with severe gastrointestinal disease, active peptic ulcer, chronic hemorrhagic gastritis, chronic hepatitis B, decompensated hepatic dysfunction, active hepatitis, etc.; 4. patients with severe hematological system diseases; 5. malignant tumors; 6. severe gynecological hemorrhagic disease.

Design outcomes

Primary

MeasureTime frame
blood regular test;Creatinine;Uric acid;—

Secondary

MeasureTime frame
Urinary protein excretion;Calcium;Phosphorus;Ferritin;Lipids;—

Countries

China

Contacts

Public ContactCHEN NAN
cnrj100@126.com+86 021 64370045-665233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026